SynthesisCancer metastasis reviews2026

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

Anna Amela Valsecchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.